alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 83, Number 14 (Monday, January 22, 2018)]
[Notices]
[Page 2981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01021]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission


Combined Notice of Filings

    Take notice that the Commission has received the following Natural 
Gas Pipeline Rate and Refund Report filings:

    Docket Numbers: RP18-345-000.
    Applicants: Northern Natural Gas Company.
    Description: Sec.  4(d) Rate Filing: 20180112 Remove Non Conforming 
to be effective 12/22/2017.
    Filed Date: 1/12/18.
    Accession Number: 20180112-5054.
    Comments Due: 5 p.m. ET 1/24/18.

    Docket Numbers: RP18-346-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: Sec.  4(d) Rate Filing: 011218 Negotiated Rates--
Consolidated Edison Energy Inc. R-2275-13 to be effective 1/15/2018.
    Filed Date: 1/12/18.
    Accession Number: 20180112-5056.
    Comments Due: 5 p.m. ET 1/24/18.

    Docket Numbers: RP18-347-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: Sec.  4(d) Rate Filing: 011218 Negotiated Rates--
Macquarie Energy LLC H-4090-89 to be effective 1/15/2018.
    Filed Date: 1/12/18.
    Accession Number: 20180112-5057.
    Comments Due: 5 p.m. ET 1/24/18.

    The filings are accessible in the Commission's eLibrary system by 
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above 
proceedings must file in accordance with Rules 211 and 214 of the 
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00 
p.m. Eastern time on the specified comment date. Protests may be 
considered, but intervention is necessary to become a party to the 
proceeding.
    eFiling is encouraged. More detailed information relating to filing 
requirements, interventions, protests, service, and qualifying 
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call (866) 208-3676 
(toll free). For TTY, call (202) 502-8659.

    Dated: January 16, 2018.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2018-01021 Filed 1-19-18; 8:45 am]
 BILLING CODE 6717-01-P
EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report on Form 10-Q of QNB Corp. (the
"Company for the period ended March 31, 2003, as filed with the Securities and
Exchange Commission (the "Report"), I, Bret H. Krevolin, Chief Accounting
Officer, of the Company, certify, pursuant to 18 U.S.C. ss.1350, as added by ss.
906 of the Sarbanes-Oxley Act of 2002, that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. To my knowledge, the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company as of and for the period covered by the Report.


Date:    May 14, 2003                               By: /s/  Bret H. Krevolin
         ------------                               --------------------------
                                                    Bret H. Krevolin
                                                    Chief Financial Officer
Jorge PIEKAREWICZ and J.D. Rayburn, Appellants, v. KILLEARN HOMES ASSOCIATION, INC., United National Bank, and Palmetto Club Properties Limited Partnership, Appellees.

No. 1D16-4799

District Court of Appeal of Florida, First District.

January 31, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
# C_2021202EN.01000101.xml

| 28.5.2021 | EN | Official Journal of the European Union | C 202/1 |
| --- | --- | --- | --- |

28.5.2021

EN

Official Journal of the European Union

C 202/1

---

EUROPEAN PARLIAMENT

2019-2020 SESSION

Sittings of 9 and 10 October 2019

The Minutes of this session have been published in OJ C 145, 23.4.2021.

TEXTS ADOPTED

Sittings of 21 to 24 October 2019

The Minutes of this session have been published in OJ C 157, 30.4.2021.

The texts adopted of 23 October 2019 concerning the discharge for the financial year 2017 have been published in OJ L 333, 27.12.2019.

TEXTS ADOPTED

---
----

**Exhibit 32.2**

**  **

** **

**CERTIFICATE OFPRINCIPAL FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION1350, AS ENACTED PURSUANT TO**

**SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

 

In connection with the Quarterly Reportof Seitel, Inc. on Form 10-Q for the quarter ended September 30, 2006, as filed withthe Securities and Exchange Commission on the date hereof (the"Report"), I, William J. Restrepo, Principal Financial Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge andbelief, that:

 
| (1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | The Report fully complies with  the requirements of section 13(a) or 15(d) of the Securities Exchange Act of  1934; and

  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|
| (2)

The information contained in  the Report fairly presents, in all material respects, the financial condition  and results of operations of the Company.

 

Date: November 1, 2006

  /s/ William J. Restrepo

William J. Restrepo

Principal Financial Officer

 

A signed original of this writtenstatement, required by Section 906, has been provided to the Company and willbe furnished to the Securities and Exchange Commission or its staff uponrequest.

 

  |
[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Page 3177]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01078]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Clinical Trials 
Review Committee.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
Clinical Trials Review Committee.
    Date: February 22-23, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn, Bethesda 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 
301-827-7912, <a href="/cdn-cgi/l/email-protection#c0a3afb0a5aba180ada1a9aceeaea9a8eea7afb6"><span class="__cf_email__" data-cfemail="88ebe7f8ede3e9c8e5e9e1e4a6e6e1e0a6efe7fe">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: January 17, 2018.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01078 Filed 1-22-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**EXHIBIT 31.1****CERTIFICATION**     I, Christopher Clemente, certify that:     1.       I have reviewed this report on Form 10-K of Comstock Homebuilding Companies, Inc.;     2.       Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this report;     3.       Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations, and cash flows of the registrant as of, and for, the periods presented in this report;     4.       The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
Exhibit 31.1**SECTION 302 CERTIFICATION**I, Gerald G. Barton, certify that:1. I have reviewed this report on Form 10-QSB of Landmark Land Company, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the small business issuer as of, and for, the periodspresented in this report; 4. The small business issuer’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in the ExchangeAct Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as definedin Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have: a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the small business issuer, including its consolidated subsidiaries,is made known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) Evaluated the effectiveness of the small business issuer’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  c) Disclosed in this report any change in the small business issuer’s internal controlover financial reporting that occurred during the small business issuer’s most recentfiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materially affect, thesmall business issuer’s internal control over financial reporting; and5. The small business issuer’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to the small businessissuer’s auditors and the audit committee of the small business issuer’s board of directors(or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe small business issuer’s ability to record, process, summarize and report financialinformation; and  b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the small business issuer’s internal control over financialreporting.   Date: November 14, 2005 /s/ GERALD G. BARTON     Gerald G. Barton  Chairman and Chief Executive Officer
|                          | Winland Electronics, Inc. |                                  |
|-------------------------------|---------------------------|---------------------------------------|
|                          |                      |                                  |   |
| Date:  November 12, 2010 | By:                       | /s/ Thomas J. de Petra           |   |
|                          |                      | Thomas J. de Petra                    |   |
|                          |                      | President and Chief Executive Officer |   |
|                          |                      |                                  |   |
Oscar Dennis HERNANDEZ, Jr., Appellant/Petitioner(s), v. Toni Lynne SEXTON, Appellee/Respondent(s).

CASE NO.: 2D17-3278

District Court of Appeal of Florida, Second District.

September 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
PRD Label Data Report: Food/Feed & Non-Food/Non-Feed Uses Considered in Registration Review Work Planning

Butralin (106501)

Fo

o

d (F) /

N

on-fo

o

d

Use Site Formulation Desc

A. I. Max App 

Rate/App

Max # Apps / 

CC

A. I. Max 

App 

Rate/CC

Max # 

Apps / 

Year

A. I. Max App 

Rate/Year

Minimum 

Retreatment 

Interval

Minimum 

Reentry

Interval PGI / PHI / PSI Allow Geo Restrictions

DisAllow Geo 

Restrictions Limitations

Current As Of Date : 05/22/2012

Note: This is an aggregate report of registered uses for this chemical. Label data for chemicals with more than one pesticide product are presented in aggregate form (i.e. each line of data may be a combination of data from one or more pesticide).

Use Site Formulation Desc Rate/App CC Rate/CC Year Rate/Year Interval Interval PGI / PHI / PSI Allow Geo Restrictions Restrictions Limitations

N TOBACCO EMULSIFIABLE CONCENTRATE .0002 lb / plant 1 NS NS NS NS 12 hr H01(7) No Restrictions No Restrictions C46 || CAU || CDC || CPE || CWJ || CWK || CWL || CWT || CWV

N TOBACCO EMULSIFIABLE CONCENTRATE 3 lb / a 1 NS NS NS NS 12 hr H01(7) No Restrictions No Restrictions C46 || CAU || CDC || CPE || CWJ || CWK || CWL || CWT || CWV

Limitation 

Code Limitation Description

C (46) Do not apply through any type of irrigation system.

C (AU) Do not apply directly to water, or to areas where surface water is present or to intertidal areas below 

C (DC) Do not apply when drift is likely to occur.

C (PE) PPE (Protective Personal Equipment) language is found on the label. Please see issues report to read 

Each row of this report is determined by the unique combination of the food/nonfood indicator, use site, formulation, and 

maximum application rate per application (key columns). The remaining, non-key columns of the report display either 

worse case or aggregate data from the label information that defines the unique data row. Note that each non-key 

column does not necessarily relate to any other non-key column with in the same row.

C (WT) Do not contaminate water intended for irrigation or domestic purposes.

C (WJ) This pesticide is toxic to aquatic invertebrates.

C (WV) Do not contaminate water by cleaning of equipment or disposal of waste.

H (01) __ day(s) preharvest interval.

C (WK) This product is toxic to fish.

C (WL) Do not contaminate water, food, or feed by storage or disposal.

NS= Not Specified

Page 1 of 1
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [S-150-2017]

On September 25, 2017, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board docketed an application submitted by the Greater Cincinnati FTZ, Inc., grantee of FTZ 47, requesting subzone status subject to the existing activation limit of FTZ 47, on behalf of Valeo North America, Inc., in Winchester, Kentucky.

                    The application was processed in accordance with the FTZ Act and Regulations, including notice in the                     **Federal Register**                     inviting public comment (82 FR 45263, September 28, 2017). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval. Pursuant to the authority delegated to the FTZ Board Executive Secretary (15 CFR Sec. 400.36(f)), the application to establish Subzone 47D was approved on November 20, 2017, subject to the FTZ Act and the Board's regulations, including Section 400.13, and further subject to FTZ 47's 2,000-acre activation limit.                

Dated: January 17, 2018.

Elizabeth Whiteman,

Acting Executive Secretary.

[FR Doc. 2018-01042 Filed 1-19-18; 8:45 am]

 BILLING CODE 3510-DS-P
Exhibit 99.1


                                 CERTIFICATION

I, Jimmy Whang, certify that:

         1.   I have reviewed this annual report on Form 10-K in respect of the
              STRATS(SM) Trust For DaimlerChrysler NA Holding Securities,
              Series 2004-10 (the "Trust") and all reports on Form 8-K
              containing distribution or servicing reports filed in respect of
              periods included in the year covered by this annual report of the
              Trust;

         2.   Based on my knowledge, the information in these reports, taken as
              a whole, does not contain any untrue statement of a material fact
              or omit to state a material fact necessary to make the statements
              made, in light of the circumstances under which such statements
              were made, not misleading as of the last day of the period
              covered by this annual report;

         3.   Based on my knowledge, the distribution or servicing information
              required to be provided to the Depositor by the Trustee under the
              trust agreement, for inclusion in these reports is included in
              these reports;

         4.   I am responsible for reviewing the activities performed by the
              Depositor and the Trustee under the trust agreement and based
              upon my knowledge and the annual compliance review required under
              that agreement, and except as disclosed in the reports, the
              Depositor and Trustee have each fulfilled its obligations under
              that agreement; and

         5.   The reports disclose all significant deficiencies relating to the
              compliance by the Trustee and the Depositor with the minimum
              servicing or similar standards based upon the report provided by
              an independent public accountant, after conducting a review in
              compliance with the Uniform Single Attestation Program for
              Mortgage Bankers or similar procedure, as set forth in the trust
              agreement that is included in these reports.

In giving the certifications above, I have reasonably relied on information
provided to me by the following unaffiliated party: U.S. Bank Trust National
Association, as Trustee.

Date: March 28, 2005

/s/ Jimmy Whang
-------------------
Name:   Jimmy Whang
Title:  Director
EXHIBIT 32.1
                                                                    ------------



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Report of Synthetech, Inc. (the "Company") on Form 10-Q
for the quarterly period ended June 30, 2003 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, M. Sreenivasan, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.   The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.


                                                  /s/ M. Sreenivasan
                                                  ----------------------
                                                  M. Sreenivasan
                                                  President & C.E.O.
                                                  July 31, 2003

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Synthetech, Inc. and will be
retained by Synthetech, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.